Skip to main content
Caplight Logo









Hologen

Hologen

Private
LondonHealthcare & Life Scienceshttps://hologen.ai/

Last Round

Series A

Jan 28, 2026

Est. Valuation

$1B

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hologen is an AI biotechnology company that develops multi-modal generative AI models to improve the understanding, design, evaluation, and delivery of treatments for neurological and other complex health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Foundation

Keywords

large medicine modelsLMMgenerative AIdrug discoverybiotech AIclinical trial optimizationfoundation modelmultimodal AIprecision medicinein silico drug designclinical data integrationAI drug discoveryreal-world evidencetherapeutic developmentAI biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hologen Comparables

Compare Hologen with similar companies based on industry and business-model similarity.

Hologen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bioptimus
81%
Insilico Medicine
78%
Valo Health
78%

Hologen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 28, 2026
VC RoundNov 27, 2025
SeedJul 1, 2025

Key People

Founding team and executive leadership

Chris Goddard

CTO & Co-founder

Founding Team

M. Jorge Cardoso

Co-Founder Chief AI Officer

Founding Team

Dean Worrall

Chief Financial Officer

Executive Team

Hologen Investors

Notable investors and investment history

Hologen investors
InvestorRounds
2468 VenturesSeed
SW7 GroupSeed
UCL BusinessSeed
Meridian Health VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 243% MoM, reaching 5.3K.

  • Aug 1, 2026

    Grew 18% QoQ, from 33 to 39 employees.

Hologen Filings

Explore SEC and related filing metadata, where available.

Hologen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hologen's valuation, stock price, and market status.

Is Hologen a public or private company?

Hologen is a private company.

What is the current stock price of Hologen?

Hologen is a private company with no public stock price. No recent secondary market data is available.

How much is Hologen worth (valuation)?

Valuation information for Hologen is not publicly available.

Can I buy Hologen stock?

Hologen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hologen's last funding round?

Hologen's most recent funding round was Series A on January 28, 2026.

Who are the main investors in Hologen?

Key investors in Hologen include 2468 Ventures, UCL Business.

Will Hologen IPO soon?

No public IPO plans have been announced for Hologen.

How can I track Hologen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hologen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range30
Year Founded2023
Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?